Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

Market Cap	8.55B +41.3%
Revenue (ttm)	2.83B +34.0%
Net Income	187.25M -37.4%
EPS	0.76 -41.6%
Shares Out	249.40M
PE Ratio	45.17
Forward PE	25.83
Dividend	0.25 (0.72%)
Ex-Dividend Date	Jul 10, 2025

Volume	4,112,225
Average Volume	7,073,784
Open	34.60
Previous Close	34.76
Day's Range	34.12 - 35.27
52-Week Range	25.60 - 43.60
Beta	0.05
RSI	39.46
Earnings Date	Mar 18, 2026

About SHA:688639

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-pantothenate calcium, D-panthenol, and inositol; bio-based new material monomers, including 1,3-propanediol and succinic acid; and other products, including malic acid and arbutin. Its products are used in daily chemical produ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 2,191
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688639

Financial Performance

In 2024, SHA:688639's revenue was 2.18 billion, an increase of 12.37% compared to the previous year's 1.94 billion. Earnings were 189.52 million, a decrease of -57.80%.